Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT05798520
Status:
RECRUITING
Last Update Posted:
2025-06-22
First Post:
2023-03-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009103', 'term': 'Multiple Sclerosis'}], 'ancestors': [{'id': 'D020278', 'term': 'Demyelinating Autoimmune Diseases, CNS'}, {'id': 'D020274', 'term': 'Autoimmune Diseases of the Nervous System'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D003711', 'term': 'Demyelinating Diseases'}, {'id': 'D001327', 'term': 'Autoimmune Diseases'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C000722588', 'term': 'BIIB091'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SEQUENTIAL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 275}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-07-25', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-06', 'completionDateStruct': {'date': '2027-09-07', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-06-20', 'studyFirstSubmitDate': '2023-03-23', 'studyFirstSubmitQcDate': '2023-03-23', 'lastUpdatePostDateStruct': {'date': '2025-06-22', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-04-04', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2027-09-07', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Part 1: Number of Participants With Adverse Events (AEs)', 'timeFrame': 'Day 1 up to Week 50', 'description': 'An AE is any untoward medical occurrence in a participant or clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product or auxiliary medicinal product, whether or not related to the medicinal (investigational) product or auxiliary medicinal product.'}, {'measure': 'Part 1: Number of Participants With Serious Adverse Events (SAEs)', 'timeFrame': 'From signing the informed consent form (ICF) to Week 50', 'description': 'SAE is any untoward medical occurrence that at any dose results in death, in the view of the investigator, places the participant at immediate risk of death (a life-threatening event), requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, results in a congenital anomaly/birth defect or is a medically important event.'}, {'measure': 'Part 2: Cumulative Number of New T1 Gadolinium-Enhancing (GdE) Lesions', 'timeFrame': 'Week 8 to Week 16'}], 'secondaryOutcomes': [{'measure': 'Part 1: Cumulative Number of New T1 Gadolinium-Enhancing (GdE) Lesions', 'timeFrame': 'Week 8 to Week 16'}, {'measure': 'Part 1: Cumulative Number of New or Enlarging T2 Hyperintense Lesions', 'timeFrame': 'Week 8 to Week 16'}, {'measure': 'Part 1: Cumulative Volume of New or Enlarging T2 Hyperintense Lesions', 'timeFrame': 'Week 8 to Week 16'}, {'measure': "Part 1: Mean Change From Baseline in QT Interval Corrected for Heart Rate Using Fridericia's Formula (QTcF), RR, PR, QRS, and QT Intervals", 'timeFrame': 'Up to Week 50'}, {'measure': 'Part 1: Number of Participants With Change From Baseline in Heart Rate', 'timeFrame': 'Up to Week 50'}, {'measure': 'Part 1: Number of Participants With Clinically Significant Electrocardiogram (ECG) Abnormalities', 'timeFrame': 'Up to Week 50'}, {'measure': 'Part 2: Cumulative Number of New or Enlarging T2 Hyperintense Lesions', 'timeFrame': 'Week 8 to Week 16'}, {'measure': 'Part 2: Cumulative Volume of New or Enlarging T2 Hyperintense Lesions', 'timeFrame': 'Week 8 to Week 16'}, {'measure': 'Part 2: Number of Participants With AEs', 'timeFrame': 'Day 1 up to Week 50', 'description': 'An AE is any untoward medical occurrence in a participant or clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product or auxiliary medicinal product, whether or not related to the medicinal (investigational) product or auxiliary medicinal product.'}, {'measure': 'Part 2: Number of Participants With SAEs', 'timeFrame': 'From signing of ICF up to Week 50', 'description': 'SAE is any untoward medical occurrence that at any dose results in death, in the view of the investigator, places the participant at immediate risk of death (a life-threatening event), requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, results in a congenital anomaly/birth defect or is a medically important event.'}, {'measure': 'Part 2: Number of Participants With Change From Baseline in QTcF, RR, PR, QRS, and QT intervals', 'timeFrame': 'Up to Week 50'}, {'measure': 'Part 2: Number of Participants With Change From Baseline in Heart Rate', 'timeFrame': 'Up to Week 50'}, {'measure': 'Part 2: Number of Participants With ECG Abnormalities as Assessed by 12-Lead ECG Measurements', 'timeFrame': 'Up to Week 50'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Multiple Sclerosis', 'Diroximel fumarate', 'BIIB091'], 'conditions': ['Relapsing Forms of Multiple Sclerosis']}, 'descriptionModule': {'briefSummary': 'In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is a 2-part study.\n\nIn Part 1, one set of participants will take either BIIB091 or diroximel fumarate (DRF). In Part 2, a different set of participants will take either a combination of BIIB091 and DRF or DRF alone.\n\nThe goal of the study is to learn more about the safety of BIIB091 and to compare the effects of the study drug when taken alone or together with DRF.\n\nThe main question researchers are trying to answer are:\n\n* How many participants have new or worsening medical problems (adverse events) after taking BIIB091 or DRF?\n* How many new areas of inflammation occur in the brain after treatment with BIIB091 and DRF?\n\nResearchers will use magnetic resonance imaging (MRI) scans to compare images of the brain before and after treatment. They will also explore the effect of BIIB091 and DRF on the heart using electrocardiograms (ECGs).\n\nThe study will be done as follows:\n\n* After screening, participants who joined Part 1 will be randomly assigned to receive either a high or low dose of BIIB091, or the standard dose of DRF.\n* The results of Part 1 will be used to choose the best dose of BIIB091 to use in Part 2.\n* Participants who join Part 2 will be randomly assigned to receive either a standard dose of DRF, a combo of BIIB091 and the standard dose of DRF, or a combo of BIIB91 with a low dose of DRF.\n* Neither the researchers nor the participants will know which drug or dose the participants will receive in either part of the study.\n* The treatment period will last 48 weeks in each part of the study. Participants will take the drugs by mouth 2 times a day.\n* Each part will also have a follow-up safety period that lasts up to 2 weeks.\n* In total, participants in each part will have 20 study visits, or more if they have a relapse. The total study duration for participants will be up to 54 weeks.', 'detailedDescription': 'The primary objectives of this study are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis (RMS) in Part 1 and to evaluate the effects of BIIB091 combination therapy with DRF compared with the DRF monotherapy arm on the key MRI measure of active central nervous system (CNS) inflammation in Part 2.\n\nThe secondary objectives of Part 1 of the study are to evaluate the effects of BIIB091 monotherapy on the MRI measures of active CNS inflammation and to assess the effect of BIIB091 monotherapy on QTc and other ECG parameters. The secondary objectives of Part 2 are to evaluate the effects of BIIB091 combination therapy with DRF compared with the DRF monotherapy arm on additional MRI measures of active CNS inflammation, the safety and tolerability of BIIB091 combination therapy with DRF in participants with RMS, and the effect of BIIB091 combination therapy with DRF on QTc and other ECG parameters.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '55 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Key Inclusion Criteria:\n\n1. Diagnosis of RMS \\[relapsing-remitting multiple sclerosis (RRMS) or active secondary progressive multiple sclerosis (SPMS)\\] in accordance with the 2017 Revised McDonald criteria.\n2. Time since MS symptom onset is \\<20 years.\n3. Must have expanded disability status scale (EDSS) score of 0 through 5.0 at screening and baseline.\n4. Must have at least 1 of the following occurring prior to Baseline (Day 1):\n\n * ≥2 clinical relapses in the last 24 months (but not within 30 days prior to Baseline \\[Day 1\\]) with at least 1 relapse during the last 12 months prior to randomization.\n * ≥1 clinical relapse within the past 24 months (but not within 30 days prior to Baseline \\[Day 1\\]) and ≥1 new brain MRI lesion (Gd-positive and/or new or enlarging T2 hyperintense lesion) within the past 12 months prior to randomization. The screening MRI could be used to satisfy this criterion (if needed for inclusion, local reading is required). For new or enlarging T2 hyperintense lesions, the reference scan cannot be \\>12 months prior to randomization.\n * ≥1 GdE lesion on brain MRI within 6 months prior to randomization.\n\nKey Exclusion Criteria:\n\n1. Diagnosis of primary progressive multiple sclerosis (PPMS) in accordance with the 2017 Revised McDonald criteria.\n2. An MS relapse that has occurred within 30 days prior to Baseline (Day 1) or the participant has not stabilized from a previous relapse at the time of screening.\n3. History of severe allergic, anaphylactic reactions or hypersensitivity reaction to BIIB091 or DRF, the excipients contained in the formulation, and if appropriate, any diagnostic agents to be administered during the study, including the following:\n\n * Known hypersensitivity to any components of the study treatment\n * Known hypersensitivity to previous fumarate or bruton's tyrosine kinase (BTK) inhibitor treatments\n * History of hypersensitivity to parenteral administration of Gd-based contrast agents\n4. Evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within the past 4 weeks prior to Baseline.\n5. History of human immunodeficiency virus (HIV) infection or a positive or indeterminate test result at screening for HIV.\n6. Current or history of hepatitis C infection regardless of viral load.\n7. Current or history of hepatitis B infection.\n8. Current enrollment or plan to enroll in any other drug, biological, device, clinical study, or treatment with an investigational drug or approved therapy for investigational use within 90 days prior to randomization or 5 half-lives of the drug or therapy, whichever is longer.\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply."}, 'identificationModule': {'nctId': 'NCT05798520', 'acronym': 'FUSION', 'briefTitle': 'A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)', 'organization': {'class': 'INDUSTRY', 'fullName': 'Biogen'}, 'officialTitle': 'A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis', 'orgStudyIdInfo': {'id': '257MS201'}, 'secondaryIdInfos': [{'id': '2022-502552-31', 'type': 'OTHER', 'domain': 'EU CT NUMBER'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Part 1: BIIB091 High Dose + Matching Placebo for DRF', 'description': 'Participants will receive BIIB091 high dose and matching placebo for DRF, orally, for up to 48 weeks.', 'interventionNames': ['Drug: BIIB091', 'Drug: Placebo']}, {'type': 'EXPERIMENTAL', 'label': 'Part 1: BIIB091 Low Dose + Matching Placebo for DRF', 'description': 'Participants will receive BIIB091 low dose and matching placebo for DRF, orally, for up to 48 weeks.', 'interventionNames': ['Drug: BIIB091', 'Drug: Placebo']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Part 1: DRF + Matching Placebo for BIIB091', 'description': 'Participants will receive DRF standard dose and matching placebo for BIIB091, orally, for up to 48 weeks.', 'interventionNames': ['Drug: DRF', 'Drug: Placebo']}, {'type': 'EXPERIMENTAL', 'label': 'Part 2: BIIB091 + DRF Standard Dose', 'description': 'Participants will receive selected dose of BIIB091 (based on Part 1 data) and DRF standard dose, orally, for up to 48 weeks.', 'interventionNames': ['Drug: BIIB091', 'Drug: DRF']}, {'type': 'EXPERIMENTAL', 'label': 'Part 2: BIIB091 + DRF Low Dose', 'description': 'Participants will receive selected dose of BIIB091 (based on Part 1 data) and DRF low dose, orally, for up to 48 weeks.', 'interventionNames': ['Drug: BIIB091', 'Drug: DRF']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Part 2: DRF + Matching Placebo for BIIB091', 'description': 'Participants will receive DRF standard dose and matching placebo for BIIB091, orally, for up to 48 weeks.', 'interventionNames': ['Drug: DRF', 'Drug: Placebo']}], 'interventions': [{'name': 'BIIB091', 'type': 'DRUG', 'description': 'Administered as specified in the treatment arm.', 'armGroupLabels': ['Part 1: BIIB091 High Dose + Matching Placebo for DRF', 'Part 1: BIIB091 Low Dose + Matching Placebo for DRF', 'Part 2: BIIB091 + DRF Low Dose', 'Part 2: BIIB091 + DRF Standard Dose']}, {'name': 'DRF', 'type': 'DRUG', 'description': 'Administered as specified in the treatment arm.', 'armGroupLabels': ['Part 1: DRF + Matching Placebo for BIIB091', 'Part 2: BIIB091 + DRF Low Dose', 'Part 2: BIIB091 + DRF Standard Dose', 'Part 2: DRF + Matching Placebo for BIIB091']}, {'name': 'Placebo', 'type': 'DRUG', 'description': 'Administered as specified in the treatment arm.', 'armGroupLabels': ['Part 1: BIIB091 High Dose + Matching Placebo for DRF', 'Part 1: BIIB091 Low Dose + Matching Placebo for DRF', 'Part 1: DRF + Matching Placebo for BIIB091', 'Part 2: DRF + Matching Placebo for BIIB091']}]}, 'contactsLocationsModule': {'locations': [{'zip': '85251', 'city': 'Scottsdale', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '602-406-6262'}, {'name': 'Suraj A. Muley', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'HonorHealth Neurology', 'geoPoint': {'lat': 33.50921, 'lon': -111.89903}}, {'zip': '94705', 'city': 'Berkeley', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '510-204-8140'}, {'name': 'Joanna A. Cooper', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Alta Bates Summit Medical Center', 'geoPoint': {'lat': 37.87159, 'lon': -122.27275}}, {'zip': '92868', 'city': 'Orange', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '949-824-9775'}, {'name': 'Michael Sy', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of California at Irvine Medical Center', 'geoPoint': {'lat': 33.78779, 'lon': -117.85311}}, {'zip': '80045', 'city': 'Aurora', 'state': 'Colorado', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '303-724-4172'}, {'name': 'Enrique Alvarez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Colorado School of Medic', 'geoPoint': {'lat': 39.72943, 'lon': -104.83192}}, {'zip': '33136', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '3052435754'}, {'name': 'Silvia Rosa Delgado', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Miami Miller School of Medicine', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33612', 'city': 'Tampa', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '8139749423'}, {'name': 'Derrick Scott Robertson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of South Florida', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '32960', 'city': 'Vero Beach', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '7724927051'}, {'name': 'Stuart James Shafer', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Vero Beach Neurology and Research Institute', 'geoPoint': {'lat': 27.63864, 'lon': -80.39727}}, {'zip': '46804', 'city': 'Fort Wayne', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '260-460-3214'}, {'name': 'Ajay Gupta', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fort Wayne Neurological Center', 'geoPoint': {'lat': 41.1306, 'lon': -85.12886}}, {'zip': '66160', 'city': 'Kansas City', 'state': 'Kansas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '913-588-6980'}, {'name': 'Sharon G. Lynch', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Kansas Medical Center Research Institute, Inc.', 'geoPoint': {'lat': 39.11417, 'lon': -94.62746}}, {'zip': '21093', 'city': 'Lutherville', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '410-828-4629'}, {'name': 'Daniel Becker', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'International Neurorehabilitation Institute', 'geoPoint': {'lat': 39.42122, 'lon': -76.62608}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '314-362-3293'}, {'name': 'Robert T. Naismith', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Washington University', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '07666', 'city': 'Teaneck', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '2018370727'}, {'name': 'Mary Ann Picone', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Holy Name', 'geoPoint': {'lat': 40.8976, 'lon': -74.01597}}, {'zip': '87131-0001', 'city': 'Albuquerque', 'state': 'New Mexico', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '917-318-4982'}, {'name': 'Clotilde Hainline', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of New Mexico', 'geoPoint': {'lat': 35.08449, 'lon': -106.65114}}, {'zip': '11772', 'city': 'Patchogue', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '631-758-1910', 'phoneExt': '2246'}, {'name': 'Mark Gudesblatt', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'South Shore Neurologic Associates, P.C.', 'geoPoint': {'lat': 40.76565, 'lon': -73.01511}}, {'zip': '27157', 'city': 'Winston-Salem', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '336-713-2545'}, {'name': 'Nuhad Abou Zeid', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Wake Forest University - School of Medicine - Central', 'geoPoint': {'lat': 36.09986, 'lon': -80.24422}}, {'zip': '45267', 'city': 'Cincinnati', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '937-535-5010'}, {'name': 'Lawrence Phillip Goldstick', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Cincinnati Physicians Company', 'geoPoint': {'lat': 39.12711, 'lon': -84.51439}}, {'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '2166369398'}, {'name': 'Devon Scott Conway', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Cleveland Clinic Foundation', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '43235', 'city': 'Columbus', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '614-304-3444'}, {'name': 'Aaron L. Boster', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Boster Center for Multiple Sclerosis', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '38018', 'city': 'Cordova', 'state': 'Tennessee', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '901-866-9252'}, {'name': 'Lee S. Stein', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Neurology Clinic, PC', 'geoPoint': {'lat': 35.15565, 'lon': -89.7762}}, {'zip': '37215', 'city': 'Nashville', 'state': 'Tennessee', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '615-343-1178'}, {'name': 'Siddharama S Pawate', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Vanderbilt MS Center', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '78229-3900', 'city': 'San Antonio', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '210-450-0500'}, {'name': 'Tania Reyna', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The University of Texas Health Science Center San Antonio', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '53792', 'city': 'Madison', 'state': 'Wisconsin', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '608-287-2090'}, {'name': 'Christopher C. Luzzio', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Wisconsin Hospital and Clinics', 'geoPoint': {'lat': 43.07305, 'lon': -89.40123}}, {'zip': '53226', 'city': 'Milwaukee', 'state': 'Wisconsin', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '4149550619'}, {'name': 'Ahmed Zayed Obeidat', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Medical College of Wisconsin', 'geoPoint': {'lat': 43.0389, 'lon': -87.90647}}, {'zip': '5800', 'city': 'Pleven', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359889361500'}, {'name': 'Hristo Lilovski', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "'MHAT Avis - Medica' OOD", 'geoPoint': {'lat': 43.41791, 'lon': 24.61666}}, {'zip': '5800', 'city': 'Pleven', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359887381827'}, {'name': 'Maya Danovska-Mladenova', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "UMHAT 'Dr. Georgi Stranski', EAD", 'geoPoint': {'lat': 43.41791, 'lon': 24.61666}}, {'zip': '4002', 'city': 'Plovdiv', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359885247929'}, {'name': 'Georgi Slavov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "UMHAT 'Sv. Georgi', EAD", 'geoPoint': {'lat': 42.15387, 'lon': 24.75001}}, {'zip': '1113', 'city': 'Sofia', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359888707880'}, {'name': 'Ivan Gospodinov Milanov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "MHATNP 'Sv.Naum', EAD", 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1142', 'city': 'Sofia', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359896660601'}, {'name': 'Dimitar Maslarov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "University First MHAT-Sofia, 'St. Joan Krastitel' EAD", 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1407', 'city': 'Sofia', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359884933001'}, {'name': 'Ivan Staikov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Acibadem City Clinic Tokuda University Hospital Ead', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1408', 'city': 'Sofia', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '359895555797'}, {'name': 'Rosen Ikonomov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'DCC Neoclinic EAD', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1431', 'city': 'Sofia', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '35928526940'}, {'name': 'Penko Minkov Shotekov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'UMHAT "Sv. Ivan Rilski", EAD', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1680', 'city': 'Sofia', 'status': 'RECRUITING', 'country': 'Bulgaria', 'contacts': [{'role': 'CONTACT', 'phone': '35929225914'}, {'name': 'Krasimir Genov', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Diagnostic Consultation Center CONVEX EOOD', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '65691', 'city': 'Brno', 'status': 'RECRUITING', 'country': 'Czechia', 'contacts': [{'role': 'CONTACT', 'phone': '420543182673'}, {'name': 'Michal Dufek', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fakultni nemocnice u sv. Anny v Brne', 'geoPoint': {'lat': 49.19522, 'lon': 16.60796}}, {'zip': '50005', 'city': 'Hradec Králové', 'status': 'RECRUITING', 'country': 'Czechia', 'contacts': [{'role': 'CONTACT', 'phone': '420495835214'}, {'name': 'Zbysek Pavelek', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fakultni nemocnice Hradec Kralove', 'geoPoint': {'lat': 50.20923, 'lon': 15.83277}}, {'zip': '58633', 'city': 'Jihlava', 'status': 'RECRUITING', 'country': 'Czechia', 'contacts': [{'role': 'CONTACT', 'phone': '420567157747'}, {'name': 'Ondrej Skoda', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Nemocnice Jihlava p.o.', 'geoPoint': {'lat': 49.3961, 'lon': 15.59124}}, {'zip': '14059', 'city': 'Praha 4-Krc', 'status': 'RECRUITING', 'country': 'Czechia', 'contacts': [{'role': 'CONTACT', 'phone': '420261083584'}, {'name': 'Marketa Grunermelova', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fakultni Thomayerova nemocnice'}, {'zip': '41529', 'city': 'Teplice', 'status': 'RECRUITING', 'country': 'Czechia', 'contacts': [{'role': 'CONTACT', 'phone': '420417519625'}, {'name': 'Marta Vachova', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Krajska zdravotni a.s. - Nemocnice Teplice o.z.', 'geoPoint': {'lat': 50.6404, 'lon': 13.82451}}, {'zip': '71034', 'city': 'Böblingen', 'state': 'Baden-Wurttemberg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'role': 'CONTACT', 'phone': '4970313097300'}, {'name': 'Felix Bischof', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Studienzentrum fur Neurologie und Psychiatrie', 'geoPoint': {'lat': 48.68212, 'lon': 9.01171}}, {'zip': '95445', 'city': 'Bayreuth', 'state': 'Bavaria', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'role': 'CONTACT', 'phone': '499214003440'}, {'name': 'Patrick Oschmann', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Klinikum Bayreuth GmbH- Hohe Warte', 'geoPoint': {'lat': 49.94782, 'lon': 11.57893}}, {'zip': '82008', 'city': 'Unterhaching', 'state': 'Bavaria', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'role': 'CONTACT', 'phone': '498945224360'}, {'name': 'Klaus Lehmann-Horn', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Neuropraxis Muenchen Sued', 'geoPoint': {'lat': 48.06598, 'lon': 11.61564}}, {'zip': '40225', 'city': 'Düsseldorf', 'state': 'North Rhine-Westphalia', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'role': 'CONTACT', 'phone': '492118119532'}, {'name': 'Sven Meuth', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitaetsklinikum Duesseldorf AoeR', 'geoPoint': {'lat': 51.22172, 'lon': 6.77616}}, {'zip': '57076', 'city': 'Siegen', 'state': 'North Rhine-Westphalia', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'role': 'CONTACT', 'phone': '4927131393710'}, {'name': 'Eugen Schlegel', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'ZNS - Zentrum fuer Neurologisch-Psychiatrische Studien', 'geoPoint': {'lat': 50.87481, 'lon': 8.02431}}, {'zip': '01307', 'city': 'Dresden', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'role': 'CONTACT', 'phone': '493514584465'}, {'name': 'Tjalf Ziemssen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitaetsklinikum Carl Gustav Carus TU Dresden', 'geoPoint': {'lat': 51.05089, 'lon': 13.73832}}, {'zip': '86077', 'city': 'Pozzilli', 'state': 'Isernia', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '39865929250'}, {'name': 'Diego Centonze', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'I.R.C.C.S. Neuromed-Istituto Neurologico Mediterraneo', 'geoPoint': {'lat': 41.51142, 'lon': 14.06252}}, {'zip': '90015', 'city': 'Cefalù', 'state': 'Palermo', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '+39921920470'}, {'name': 'Luigi Grimaldi', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fondazione Istituto G.Giglio di Cefalù', 'geoPoint': {'lat': 38.03856, 'lon': 14.02285}}, {'zip': '16132', 'city': 'Genova', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '39103537040'}, {'name': 'Maria Matilde Inglese', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'IRCCS Ospedale Policlinico San Martino', 'geoPoint': {'lat': 45.21604, 'lon': 11.87211}}, {'zip': '80138', 'city': 'Napoli', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '39815665299'}, {'name': 'Antonio Gallo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli"', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '27100', 'city': 'Pavia', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '39382380381'}, {'name': 'Elena Colombo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fondazione Istituto Neurologico Casimiro Mondino', 'geoPoint': {'lat': 45.19205, 'lon': 9.15917}}, {'zip': '00133', 'city': 'Roma', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '39620903384'}, {'name': 'Girolama A. Marfia', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Azienda Ospedaliera Universitaria Policlinico Tor Vergata', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '00161', 'city': 'Roma', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'role': 'CONTACT', 'phone': '39649914556'}, {'name': 'Antonella Conte', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '80-803', 'city': 'Gdansk', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48501157820'}, {'name': 'Waldemar Fryze', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'COPERNICUS Podmiot Leczniczy Sp. z o. o.,', 'geoPoint': {'lat': 54.35227, 'lon': 18.64912}}, {'zip': '05-825', 'city': 'Grodzisk Mazowiecki', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48600952698'}, {'name': 'Marta Bilik', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Samodzielny Publiczny Specjalistyczny Szpital Zachodni im. Jana Pawla II', 'geoPoint': {'lat': 52.10387, 'lon': 20.6337}}, {'zip': '40-081', 'city': 'Katowice', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48327494187'}, {'name': 'Aleksandra Porosinska', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centrum Medyczne Pratia Katowice', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '40-571', 'city': 'Katowice', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48327494187'}, {'name': 'Maciej Maciejowski', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'M.A. - LEK A.M.Maciejowscy SC.', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '40-650', 'city': 'Katowice', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48322030106'}, {'name': 'Tomasz Jerzy Zielinski', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Nzoz Novo-Med', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '25-726', 'city': 'Kielce', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48607570949'}, {'name': 'Elzbieta Jasinska', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Resmedica Sp.z o.o', 'geoPoint': {'lat': 50.87033, 'lon': 20.62752}}, {'zip': '31-503', 'city': 'Krakow', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48124248694'}, {'name': 'Agnieszka Slowik', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Szpital Uniwersytecki w Krakowie', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'zip': '90-324', 'city': 'Lodz', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48426776678'}, {'name': 'Krzysztof Selmaj', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centrum Neurologii K. Selmaj', 'geoPoint': {'lat': 51.77058, 'lon': 19.47395}}, {'zip': '32-600', 'city': 'Oświęcim', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48604517177'}, {'name': 'Magdalena Boczarska-Jedynak', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Instytut Zdrowia dr Boczarska-Jedynak sp.z.o.o, Sp.K', 'geoPoint': {'lat': 50.03437, 'lon': 19.21037}}, {'zip': '60-693', 'city': 'Poznan', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48697333515'}, {'name': 'Karolina Piasecka-Stryczynska', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Med-Polonia Sp. z o.o.', 'geoPoint': {'lat': 52.40692, 'lon': 16.92993}}, {'zip': '61-853', 'city': 'Poznan', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48618707343'}, {'name': 'Jan Ilkowski', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "NZOZ 'NEURO-KARD', 'Ilkowski i Partnerzy' Sp. Partn. Lek.", 'geoPoint': {'lat': 52.40692, 'lon': 16.92993}}, {'zip': '35-323', 'city': 'Rzeszów', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48178666981'}, {'name': 'Iwona Rosciszewska Zukowska', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Nzoz Palomed', 'geoPoint': {'lat': 50.04132, 'lon': 21.99901}}, {'zip': '01-684', 'city': 'Warsaw', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48501762789'}, {'name': 'Maciej Czarnecki', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'NeuroProtect Sp. z o.o.', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '41-800', 'city': 'Zabrze', 'status': 'RECRUITING', 'country': 'Poland', 'contacts': [{'role': 'CONTACT', 'phone': '48606607460'}, {'name': 'Monika Adamczyk Sowa', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Wielospecjalistyczne Centrum Medyczne Ibismed', 'geoPoint': {'lat': 50.32492, 'lon': 18.78576}}, {'zip': '00968', 'city': 'Guaynabo', 'state': 'San Juan', 'status': 'RECRUITING', 'country': 'Puerto Rico', 'contacts': [{'role': 'CONTACT', 'phone': '7877937984'}, {'name': 'Angel R Chinea Martinez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Caribbean Center for Clinical Research'}, {'zip': '11302', 'city': 'Bucharest', 'status': 'RECRUITING', 'country': 'Romania', 'contacts': [{'role': 'CONTACT', 'phone': '40723226233'}, {'name': 'Dan Mitrea', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'S.C Neurocity S.R.L', 'geoPoint': {'lat': 44.43225, 'lon': 26.10626}}, {'zip': '11461', 'city': 'Bucharest', 'status': 'RECRUITING', 'country': 'Romania', 'contacts': [{'role': 'CONTACT', 'phone': '40213161600109'}, {'name': 'Simona Petrescu', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Spitalul Universitar de Urgenta Elias', 'geoPoint': {'lat': 44.43225, 'lon': 26.10626}}, {'zip': '115100', 'city': 'Campulung Muscel', 'status': 'RECRUITING', 'country': 'Romania', 'contacts': [{'role': 'CONTACT', 'phone': '40248533133'}, {'name': 'Emilian Silviu Manescu', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'S.C Clubul Sanatatii SRL', 'geoPoint': {'lat': 45.26667, 'lon': 25.05}}, {'zip': '28223', 'city': 'Pozuelo de Alarcón', 'state': 'Madrid', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'role': 'CONTACT', 'phone': '34680223584'}, {'name': 'Rafael Arroyo Gonzalez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Universitario Quironsalud Madrid', 'geoPoint': {'lat': 40.43293, 'lon': -3.81338}}, {'zip': '30120', 'city': 'El Palmar', 'state': 'Murcia', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'role': 'CONTACT', 'phone': '34968369389'}, {'name': 'Jose Eustasio Meca Lallana', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Universitario Virgen de la Arrixaca', 'geoPoint': {'lat': 37.93939, 'lon': -1.16095}}, {'zip': '08003', 'city': 'Barcelona', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'role': 'CONTACT', 'phone': '34932483235'}, {'name': 'Jose Enrique Martinez Rodriguez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital del Mar', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '14011', 'city': 'Córdoba', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'role': 'CONTACT', 'phone': '34688905848'}, {'name': 'Eduardo A. Morales', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Universitario Reina Sofia', 'geoPoint': {'lat': 37.89155, 'lon': -4.77275}}, {'zip': '28034', 'city': 'Madrid', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'role': 'CONTACT', 'phone': '34913368397'}, {'name': 'Lucienne Costa Frossard Franca', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Universitario Ramon y Cajal', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '29010', 'city': 'Málaga', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'role': 'CONTACT', 'phone': '34671957249'}, {'name': 'Ana Maria Alonso Torres', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Regional Universitario de Malaga', 'geoPoint': {'lat': 36.72016, 'lon': -4.42034}}, {'zip': '6903', 'city': 'Lugano', 'state': 'Canton Ticino', 'status': 'RECRUITING', 'country': 'Switzerland', 'contacts': [{'role': 'CONTACT', 'phone': '41918116921'}, {'name': 'Chiara Zecca', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ospedale Regionale di Lugano', 'geoPoint': {'lat': 46.01008, 'lon': 8.96004}}, {'zip': '3010', 'city': 'Bern', 'status': 'RECRUITING', 'country': 'Switzerland', 'contacts': [{'role': 'CONTACT', 'phone': '41316329465'}, {'name': 'Robert Hoepner', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Inselspital - Universitaetsspital Bern', 'geoPoint': {'lat': 46.94809, 'lon': 7.44744}}, {'zip': '8091', 'city': 'Zurich', 'status': 'RECRUITING', 'country': 'Switzerland', 'contacts': [{'role': 'CONTACT', 'phone': '41442555511'}, {'name': 'Patrick Roth', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitaetsspital Zuerich', 'geoPoint': {'lat': 47.36667, 'lon': 8.55}}], 'centralContacts': [{'name': 'US Biogen Clinical Trial Center', 'role': 'CONTACT', 'email': 'clinicaltrials@biogen.com', 'phone': '866-633-4636'}, {'name': 'Global Biogen Clinical Trial Center', 'role': 'CONTACT', 'email': 'clinicaltrials@biogen.com'}], 'overallOfficials': [{'name': 'Medical Director', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Biogen'}]}, 'ipdSharingStatementModule': {'url': 'https://vivli.org/', 'ipdSharing': 'YES', 'description': "In accordance with Biogen's Clinical Trial Transparency and Data Sharing Policy on https://www.biogentrialtransparency.com/"}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Biogen', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}